Combinations of eszopiclone and Odesmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders

Details for Australian Patent Application No. 2006265008 (hide)

Owner Sepracor Inc.

Inventors Wessel, Thomas; Varney, Mark A.; Caron, Judy; Lalji, Karim

Agent Griffith Hack

Pub. Number AU-A-2006265008

PCT Pub. Number WO2007/005961

Priority 60/697,012 06.07.05 US

Filing date 5 July 2006

Wipo publication date 11 January 2007

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/005961 Priority application(s): WO2007/005961

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265009-Combinations of eszopiclone and an antidepressant

2006265002-Anti-IL-23 antibodies, compositions, methods and uses